Background As a kind of nosocomial infection pathogen which can cause high mortality, its susceptibility and death risk factors are still unclear. Aim To analyze the epidemiological characteristics of and risk factors for Elizabethkingia meningoseptica infection. Methods Relevant literature from 2011 to 2019 with the key words “E. meningoseptica” or “Elizabethkingia meningoseptica” in the title and abstract was retrieved from the PubMed database. The risk factors of infection and death for infected patients treated at Southwest Hospital during the above period were analyzed by logistic regression. Results From 2011 to 2019, 366 patients infected with E. meningoseptica were reported in 132 articles in the PubMed database. The mortality rate was 63.20%. During the same period, 92 infected patients were treated at our hospital. The overall mortality rate was approximately 28.3% (26/92) to 39.1% (36/92). The resistance rate for carbapenems was 100%; for cephalosporins, it was more than 90%; and for minocycline, it was 0. Central venous catheterization (p < 0.001), mechanical ventilation (p = 0.015), bacteria type (p < 0.001), operation type (p = 0.001), fungal infection (p < 0.001), carbapenem use (p = 0.000), and triazole use (p = 0.016) were independent risk factors for E. meningoseptica infection. According to logistic regression, bacteria type (p = 0.037), platelet level (p = 0.014), and mechanical ventilation (p = 0.043) were risk factors for death. Conclusion The incidence of E. meningoseptica infection worldwide shows a trend toward increasing yearly. Invasive operations, multiple bacterial or fungal infections and the use of carbapenems may be predisposing factors, and platelet level, bacteria type, and mechanical ventilation were risk factors for death.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.